PRECLINICAL SCHIZOPHRENIA STUDIES
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR SCHIZOPHRENIA PROGRAM.
MODELS / SERVICES
PharmaLegacy’s operational advantages:
- 1500+ validated animal models of disease spanning 100+ indications
- 30,000+ animal capacity
- Staffing and facilities to run 200+ concurrent studies
- 380,000 square feet of facilities
- Ability to start most studies in under 2 weeks
PharmaLegacy has the capability and capacity to advance your schizophrenia pipeline. Contact us today.
We’re ready when you are.
Tell us your Schizophrenia pipeline challenges.
